Poster highlights 6-month follow-up data from the ongoing Phase 2 trial of NDV-01 in non-muscle invasive bladder cancer (NMIBC), with favorable overall safety Relmada plans to advance NDV-01, a ...
Forty Iranian knowledge-based firms are participating in the Afghan Health Exhibition, being held from December 2 to 4, in Kabul.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈